New pathogenic mutation of chorea-acanthocytosis.
Garrido-Fernández A, Santos-Lasaosa S, Bellosta-Diago E, Sáchez-Valiente S.
Neurologia (Engl Ed). 2020 Mar;35(2):73-74. doi: 10.1016/j.nrl.2018.03.012. Epub 2018 May 8.
Acanthocytosis and neurological disorders.
Stevenson VL, Hardie RJ.
J Neurol. 2001 Feb;248(2):87-94. doi: 10.1007/s004150170241.
Progress in the Diagnosis and Management of Chorea-acanthocytosis.
Liu Y, Liu ZY, Wan XH, Guo Y.
Chin Med Sci J. 2018 Mar 30;33(1):53-59. doi: 10.24920/21802.
Acanthocytosis in an alectinib-treated patient.
Legland Ép Dejean AM, Plantamura J, Arnoux I, Paleiron N, Loosveld M, Buono Ép Foucher B.
Br J Haematol. 2022 Apr;197(2):131. doi: 10.1111/bjh.18020. Epub 2022 Feb 7.
Acanthocytosis: a key feature for the diagnosis of abetalipoproteinemia.
Lausch E, Yoshimi A.
Blood. 2023 Jun 29;141(26):3231. doi: 10.1182/blood.2023020260.
Marked Acanthocytosis Associated With Klipple Trenaunay Syndrom.
Ali SM, Raza N, Aftab E, Mohammad MF.
J Ayub Med Coll Abbottabad. 2023 Feb-Mar;35(1):182-185. doi: 10.55519/JAMC-01-11307.
Acanthocytosis.
Craandijk A, Houtsmuller AJ, Junge J, Aan de Kerk AL.
Ophthalmologica. 1968;156(1):91. doi: 10.1159/000305376.
Acanthocytosis in progressive childhood dystonia.
Sharawat IK, Ghosh S, Bhatia P, Bhatia V, Saini AG.
Neurol India. 2018 Jul-Aug;66(4):1204-1206. doi: 10.4103/0028-3886.237021.
Guidance for the diagnosis and treatment of hypolipidemia disorders.
Bredefeld C, Hussain MM, Averna M, Black DD, Brin MF, Burnett JR, Charrière S, Cuerq C, Davidson NO, Deckelbaum RJ, Goldberg IJ, Granot E, Hegele RA, Ishibashi S, Karmally W, Levy E, Moulin P, Okazaki H, Poinsot P, Rader DJ, Takahashi M, Tarugi P, Traber MG, Di Filippo M, Peretti N.
J Clin Lipidol. 2022 Nov-Dec;16(6):797-812. doi: 10.1016/j.jacl.2022.08.009. Epub 2022 Sep 29.
Acanthocytosis--biochemical and physiological considerations.
Biemer JJ.
Ann Clin Lab Sci. 1980 May-Jun;10(3):238-49.
